Author Archives: Warren Woessner

Akami/McKesson Decision Re-defines Induced Infringement

In a 6-5 decision, the Fed. Cir., sitting en banc, decided two appeals which presented questions closely related to when an actor is liable for inducing infringement under 271(b); Akami Technologies, Inc. v. Limelight Networks, Inc. and McKesson Tech’s., Inc. … Continue reading

Posted in Infringement | Tagged , , , , , , , , , | Leave a comment

AUTM Eastern Regional Meeting Panel to Address Patentability Challenges

Warren Woessner will be joined by two other well-known patent attorneys,  Rodney Sparks of the University of Virginia Patent Foundation and Hans Sauer of BIO, in Philadelphia on September 13th. The panel will try to update the status of the major … Continue reading

Posted in Miscellaneous | Tagged , , , , , , , , | Leave a comment

Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research

On August 24th, the D.C. Cir. ruling dismissing the suit brought to block any federal funding of embryonic stem cell research was affirmed. Stem cell researchers can breathe a bit more easily, and keep the lights on in their labs … Continue reading

Posted in Stem Cells/Cloning | Tagged , , | Leave a comment

Admissibility of Disclaimers – New Lessons From The EPO Technical Boards of Appeal

The following is a guest post from the 8/12 newsletter of Dr. Stefan Danner of DHS Patentanwaltsgesellschaft mbH.  Last year, the EPO Enlarged Board of Appeal (EBA) handed down its decision in case G2/10 relating to the admissibility of disclaimers whose … Continue reading

Posted in EP and UK Practice | Tagged , , , , , , , , | Leave a comment